Emerging cancer therapeutic opportunities target DNA-repair systems
- 30 June 2006
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 27 (6), 338-344
- https://doi.org/10.1016/j.tips.2006.04.007
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- DNA MISMATCH REPAIRAnnual Review of Biochemistry, 2005
- DNA Helicases as Targets for Anti-Cancer DrugsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage CheckpointsAnnual Review of Biochemistry, 2004
- Targeting the checkpoint kinases: chemosensitization versus chemoprotectionNature Reviews Cancer, 2004
- Repairing DNA-methylation damageNature Reviews Molecular Cell Biology, 2004
- Classification of anticancer drugs—a new system based on therapeutic targetsCancer Treatment Reviews, 2003
- Repair of and checkpoint response to topoisomerase I-mediated DNA damageMutation research. Reviews in mutation research, 2003
- Improving the evaluation of new cancer treatments: challenges and opportunitiesNature Reviews Cancer, 2003
- Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevanceThe Lancet Oncology, 2001